Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in the Treatment of Necrotizing Enterocolitis in Premature Neonates
NCT00271336Phase 2Unknown
- Sponsor
- Shaare Zedek Medical Center
- Start
- Jan 2005
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pentoxifylline in necrotizing enterocolitis (NEC), sponsored by Shaare Zedek Medical Center. Primary endpoint: Progression to serious NEC related morbidity at 3 years. Status: unknown.
02
Drugs
pentoxifylline
03
Conditions
necrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on NCT00271336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00271336.